penetration of the pharmaceutical industry on health has formed a complex web of interests and collusion that interacts with the entire sector. Industry funds vocational training, an area of \u200b\u200b"abandoned" frivolously by the public administration, with courses, conferences, travel, meals, speakers ... and obviously not at zero cost. Health centers open their doors to visitors with gifts, large and small claims (presented as "educational opportunities") create a culture of patronage that affects professional autonomy and rationality of the prescription.
The 2006 report of Transparency International denounces the for its "complexity" and in particular the pharmacy (with a total expenditure of $ 500,000 million per year) by the "large number of actors involved in the drug chain. " The "aggressive marketing" of the drug is identified as primarily responsible. An unacceptable reality when the population of third world has difficult access to essential medicines.
Investment Industry Marketing is huge
(31% of total) compared with 14% devoted to research ... The industry pays more than 90% of continuing education: setting the agenda, speakers paid ... and this is undoubtedly marketing. Patients are also part of the fabric with subsidies to their associations and the publication of magazines and books. In addition, much of the information marketing is "overvalued" for new drugs which are more expensive to be protected by patents (no generic versions) although 80% of these medications do not provide anything new, are called "me too", by similarity to existing ones. Meanwhile, drug spending grew faster than other chapters, exceeding 30%, combined primary and hospital care, the total public health expenditure. If this trend continues in a few years is comparable to the costs of staff throughout the NHS. We are aware, when to publish the manifesto, that the malpractice and their persistence over time, have for most professionals consideration of "normalcy" of little ethical value. But there is sufficient evidence that the intervention of Industry interfere with adherence to clinical practice guidelines and quality pharmaceutical care.
The platform does not have a vocation to witness, his intention is include professionals
good practice, and not condemnation or confrontation, is to gather support within and outside the health sector, telling what happens with rigor and without sensationalism. The situation has bottomed out and we object to these "aids" that are short term, but eventually pose a high intellectual and economic cost to a society that wants maintain and improve their welfare.
0 comments:
Post a Comment